造影剤の市場規模、シェア、動向分析レポート：モダリティ別、製品別、用途別、投与経路別、最終用途別、地域別、セグメント予測、2024年～2030年

造影剤市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の造影剤市場規模は2024年から2030年にかけてCAGR 7.98%を記録し、2030年には107億4,000万米ドルに達すると予測されています。

慢性疾患の有病率の上昇が画像診断治療の需要に拍車をかけており、これが市場を前進させています。MRIなどの画像検査は、ほとんどの疾患診断において重要な側面となっており、ヘルスケアにおける画像技術の普及が造影剤需要を世界的に押し上げています。

がんや糖尿病のような慢性疾患は、急速に公衆衛生の主要な関心事となりつつあり、世界の死亡原因の上位を占めているため、早期発見技術や効果的な治療法の開発が必要とされています。その結果、画像検査と造影剤の主な促進要因の1つは、複雑な併存疾患と長期疾患の有病率の上昇であり、これが世界市場を押し上げています。

病院を訪れる患者の減少により、COVID-19の大流行は世界の造影剤市場に悪影響を及ぼしました。いくつかの放射線科では画像診断の症例数が激減しました。世界の多くの国では経済の再建が始まっているが、造影剤の使用率がパンデミック前のレベルに戻るには時間がかかると思われます。さらに、COVID-19ワクチンの発売と規制緩和により、原材料の輸出入が始まっており、予測期間を通じて市場は高い成長率を示すと思われます。

造影剤市場レポートハイライト

• モダリティ別では、X線/コンピュータ断層撮影分野が2023年に69.64%を占め、最大の市場シェアを占めました。X線/CTモダリティの幅広い受容性とコスト効率が、このモダリティに使用される造影剤の採用を後押ししています。
• 製品タイプ別では、ヨード系造影剤が2023年に65.37%を占め、最大の市場シェアを占めました。これは、他の造影剤に比べて優れた放射線透過性と低毒性によるものです。
• 用途別では、神経疾患分野が市場を席巻し、2023年には約28.59%の最大収益シェアを占めました。神経疾患に対する中枢神経系の診断評価は、CTよりも優れた神経構造の画像を提供することから、MRI造影剤の採用を後押ししています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 造影剤市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 普及と成長の見通しマッピング
• 業界のバリューチェーン分析
  • 償還の枠組み
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 造影剤市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • 主要取引と戦略的提携の分析
  • 市場参入戦略

第4章 造影剤市場：モダリティ推定・動向分析

• 定義と範囲
• モダリティ市場シェア、2023年と2030年
• セグメントダッシュボード
• 造影剤市場のモダリティ別展望
• 市場規模、予測および動向分析、2018年から2030年まで

第5章 造影剤市場：製品推定・動向分析

• 定義と範囲
• 製品市場シェア、2023年と2030年
• セグメントダッシュボード
• 製品別造影剤市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで

第6章 造影剤市場：用途推定・動向分析

• 定義と範囲
• 用途市場シェア、2023年と2030年
• セグメントダッシュボード
• 用途別造影剤市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで

第7章 造影剤市場：投与経路推定・動向分析

• 定義と範囲
• 投与経路の市場シェア、2023年と2030年
• セグメントダッシュボード
• 投与経路別造影剤市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで

第8章 造影剤市場：最終用途推定・動向分析

• 定義と範囲
• 最終用途市場シェア、2023年および2030年
• セグメントダッシュボード
• 最終用途別の造影剤市場の見通し
• 市場規模、予測および動向分析、2018年から2030年まで

第9章 造影剤市場：地域推定・動向分析

• 地域市場シェア分析、2023年および2030年
• 地域市場ダッシュボード
• 世界の地域市場のスナップショット
• 地域市場シェアと主要企業、2023年
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東とアフリカ
• 市場応用、予測および動向分析、2018年から2030年：
• 北米
  • 市場推計・予測、2018～2030年
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • 日本
  • インド
  • 中国
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 会社/競合の分類
  • イノベーター
• ベンダー情勢
  • 主要ディストリビューターとチャネルパートナーのリスト
  • 主要顧客
  • 主要企業市場シェア分析、2023年
  • Bayer AG
  • General Electric Company
  • Guerbet
  • Bracco Diagnostic, Inc.
  • Nano Therapeutics Pvt. Ltd.
  • Lantheus Medical Imaging, Inc.
  • iMAX
  • Trivitron Healthcare

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global contrast media market, by region 2018 - 2030 (USD Million)
• Table 4 Global contrast media market, by modality 2018 - 2030 (USD Million)
• Table 5 Global contrast media market, by product, 2018 - 2030 (USD Million)
• Table 6 Global contrast media market, by application 2018 - 2030 (USD Million)
• Table 7 Global contrast media market, by route of administration, 2018 - 2030 (USD Million)
• Table 8 Global contrast media market, by end-use 2018 - 2030 (USD Million)
• Table 9 North America contrast media market, by country, 2018 - 2030 (USD Million)
• Table 10 North America contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 11 North America contrast media market, by product, 2018 - 2030 (USD Million)
• Table 12 North America contrast media, by application, 2018 - 2030 (USD Million)
• Table 13 North America contrast media, by route of administration, 2018 - 2030 (USD Million)
• Table 14 North America contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 15 U.S. contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 16 U.S. contrast media market, by product, 2018 - 2030 (USD Million)
• Table 17 U.S. contrast media, by application, 2018 - 2030 (USD Million)
• Table 18 U.S. contrast media, by route of administration, 2018 - 2030 (USD Million)
• Table 19 U.S. contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 20 Canada contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 21 Canada contrast media market, by product, 2018 - 2030 (USD Million)
• Table 22 Canada contrast media, by application, 2018 - 2030 (USD Million)
• Table 23 Canada contrast media, by route of administration, 2018 - 2030 (USD Million)
• Table 24 Canada contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 25 Europe contrast media market, by country, 2018 - 2030 (USD Million)
• Table 26 Europe contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 27 Europe contrast media market, by product, 2018 - 2030 (USD Million)
• Table 28 Europe contrast media, by application, 2018 - 2030 (USD Million)
• Table 29 Europe contrast media, by route of administration, 2018 - 2030 (USD Million)
• Table 30 Europe contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 31 UK contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 32 UK contrast media market, by product, 2018 - 2030 (USD Million)
• Table 33 UK contrast media, by application, 2018 - 2030 (USD Million)
• Table 34 UK contrast media, by route of administration, 2018 - 2030 (USD Million)
• Table 35 UK contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 36 Germany contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 37 Germany contrast media market, by product, 2018 - 2030 (USD Million)
• Table 38 Germany contrast media, by application, 2018 - 2030 (USD Million)
• Table 39 Germany contrast media, by route of administration, 2018 - 2030 (USD Million)
• Table 40 Germany contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 41 France contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 42 France contrast media market, by product, 2018 - 2030 (USD Million)
• Table 43 France contrast media, by application, 2018 - 2030 (USD Million)
• Table 44 France contrast media, by route of administration, 2018 - 2030 (USD Million)
• Table 45 France contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 46 Italy contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 47 Italy contrast media market, by product, 2018 - 2030 (USD Million)
• Table 48 Italy contrast media, by application, 2018 - 2030 (USD Million)
• Table 49 Italy contrast media, by route of administration, 2018 - 2030 (USD Million)
• Table 50 Italy contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 51 Spain contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 52 Spain contrast media market, by product, 2018 - 2030 (USD Million)
• Table 53 Spain contrast media, by application, 2018 - 2030 (USD Million)
• Table 54 Spain contrast media, by route of administration, 2018 - 2030 (USD Million)
• Table 55 Spain contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 56 Sweden contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 57 Sweden contrast media market, by product, 2018 - 2030 (USD Million)
• Table 58 Sweden contrast media, by application, 2018 - 2030 (USD Million)
• Table 59 Sweden contrast media, by route of administration, 2018 - 2030 (USD Million)
• Table 60 Sweden contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 61 Norway contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 62 Norway contrast media market, by product, 2018 - 2030 (USD Million)
• Table 63 Norway contrast media, by application, 2018 - 2030 (USD Million)
• Table 64 Norway contrast media, by route of administration, 2018 - 2030 (USD Million)
• Table 65 Norway contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 66 Denmark contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 67 Denmark contrast media market, by product, 2018 - 2030 (USD Million)
• Table 68 Denmark contrast media, by application, 2018 - 2030 (USD Million)
• Table 69 Denmark contrast media, by route of administration, 2018 - 2030 (USD Million)
• Table 70 Denmark contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 71 Asia Pacific contrast media market, by country, 2018 - 2030 (USD Million)
• Table 72 Asia Pacific contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 73 Asia Pacific contrast media market, by product, 2018 - 2030 (USD Million)
• Table 74 Asia Pacific contrast media market, by route of administration, 2018 - 2030 (USD Million)
• Table 75 Asia Pacific contrast media market, by application, 2018 - 2030 (USD Million)
• Table 76 Asia Pacific contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 77 China contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 78 China contrast media market, by product, 2018 - 2030 (USD Million)
• Table 79 China contrast media market, by application, 2018 - 2030 (USD Million)
• Table 80 China contrast media market, by route of administration, 2018 - 2030 (USD Million)
• Table 81 China contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 82 India contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 83 India contrast media market, by product, 2018 - 2030 (USD Million)
• Table 84 India contrast media market, by application, 2018 - 2030 (USD Million)
• Table 85 India contrast media market, by route of administration, 2018 - 2030 (USD Million)
• Table 86 India contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 87 South Korea contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 88 South Korea contrast media market, by product, 2018 - 2030 (USD Million)
• Table 89 South Korea contrast media market, by application, 2018 - 2030 (USD Million)
• Table 90 South Korea contrast media market, by route of administration, 2018 - 2030 (USD Million)
• Table 91 South Korea contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 92 Australia contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 93 Australia contrast media market, by product, 2018 - 2030 (USD Million)
• Table 94 Australia contrast media market, by application, 2018 - 2030 (USD Million)
• Table 95 Australia contrast media market, by route of administration, 2018 - 2030 (USD Million)
• Table 96 Australia contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 97 Thailand contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 98 Thailand contrast media market, by product, 2018 - 2030 (USD Million)
• Table 99 Thailand contrast media market, by application, 2018 - 2030 (USD Million)
• Table 100 Thailand contrast media market, by route of administration, 2018 - 2030 (USD Million)
• Table 101 Thailand contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 102 Japan contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 103 Japan contrast media market, by product, 2018 - 2030 (USD Million)
• Table 104 Japan contrast media market, by application, 2018 - 2030 (USD Million)
• Table 105 Japan contrast media market, by route of administration, 2018 - 2030 (USD Million)
• Table 106 Japan contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 107 Latin America contrast media market, by country, 2018 - 2030 (USD Million)
• Table 108 Latin America contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 109 Latin America contrast media market, by product, 2018 - 2030 (USD Million)
• Table 110 Latin America contrast media market, by application, 2018 - 2030 (USD Million)
• Table 111 Latin America contrast media market, by route of administration, 2018 - 2030 (USD Million)
• Table 112 Latin America contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 113 Brazil contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 114 Brazil contrast media market, by product, 2018 - 2030 (USD Million)
• Table 115 Brazil contrast media market, by application, 2018 - 2030 (USD Million)
• Table 116 Brazil contrast media market, by route of administration, 2018 - 2030 (USD Million)
• Table 117 Brazil contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 118 Mexico contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 119 Mexico contrast media market, by product, 2018 - 2030 (USD Million)
• Table 120 Mexico contrast media market, by application, 2018 - 2030 (USD Million)
• Table 121 Mexico contrast media market, by route of administration, 2018 - 2030 (USD Million)
• Table 122 Mexico contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 123 Argentina contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 124 Argentina contrast media market, by product, 2018 - 2030 (USD Million)
• Table 125 Argentina contrast media market, by application, 2018 - 2030 (USD Million)
• Table 126 Argentina contrast media market, by route of administration, 2018 - 2030 (USD Million)
• Table 127 Argentina contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 128 Middle East & Africa contrast media market, by country, 2018 - 2030 (USD Million)
• Table 129 Middle East & Africa contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 130 Middle East & Africa contrast media market, by product, 2018 - 2030 (USD Million)
• Table 131 Middle East & Africa contrast media market, by application, 2018 - 2030 (USD Million)
• Table 132 Middle East & Africa contrast media market, by route of administration, 2018 - 2030 (USD Million)
• Table 133 Middle East & Africa contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 134 South Africa contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 135 South Africa contrast media market, by product, 2018 - 2030 (USD Million)
• Table 136 South Africa contrast media market, by application, 2018 - 2030 (USD Million)
• Table 137 South Africa contrast media market, by route of administration, 2018 - 2030 (USD Million)
• Table 138 South Africa contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 139 Saudi Arabia contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 140 Saudi Arabia contrast media market, by product, 2018 - 2030 (USD Million)
• Table 141 South Arabia contrast media market, by application, 2018 - 2030 (USD Million)
• Table 142 Saudi Arabia contrast media market, by route of administration, 2018 - 2030 (USD Million)
• Table 143 Saudi Arabia contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 144 UAE contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 145 UAE contrast media market, by product, 2018 - 2030 (USD Million)
• Table 146 UAE contrast media market, by application, 2018 - 2030 (USD Million)
• Table 147 UAE contrast media market, by route of administration, 2018 - 2030 (USD Million)
• Table 148 UAE contrast media market, by end-use, 2018 - 2030 (USD Million)
• Table 149 Kuwait contrast media market, by modality, 2018 - 2030 (USD Million)
• Table 150 Kuwait contrast media market, by product, 2018 - 2030 (USD Million)
• Table 151 Kuwait contrast media market, by application, 2018 - 2030 (USD Million)
• Table 152 Kuwait contrast media market, by route of administration, 2018 - 2030 (USD Million)
• Table 153 Kuwait contrast media market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Contrast media market: Market snapshot
• Fig. 9 Contrast media market: Market segmentation
• Fig. 10 Contrast media market Strategy framework
• Fig. 11 Parent market outlook
• Fig. 12 Related/ancillary market outlook
• Fig. 13 Contrast media market driver impact
• Fig. 14 Contrast media market restraint impact
• Fig. 15 Contrast media market Porter's five forces analysis
• Fig. 16 Contrast media market PESTEL analysis
• Fig. 17 Contrast media market segment dashboard
• Fig. 18 Contrast media market: Modality movement analysis
• Fig. 19 Ultrasound market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Magnetic resonance imaging market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 X-ray/computed tomography market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Contrast media market: Product movement analysis
• Fig. 23 Microbubble market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Gadolinium-based market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Iodinated market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Barium-based market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Contrast media market: Application movement analysis
• Fig. 28 Cardiovascular disorders market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Neurological disorders market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Gastrointestinal disorders market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Nephrological disorders market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Musculoskeletal disorders market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Gastrointestinal disorders market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Contrast media market: Route of administration movement analysis
• Fig. 36 Intravenous market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 Oral route market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 Rectal route market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 Contrast media market: End-use movement analysis
• Fig. 40 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 41 Diagnostic Imaging Centers market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 42 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 Global contrast media market: Regional movement analysis
• Fig. 44 Global contrast media market: Regional outlook and key takeaways
• Fig. 45 Global market share, by region
• Fig. 46 North America market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 Canada market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 49 Europe market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 50 UK market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 51 Germany market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 52 France market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 53 Italy market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 54 Spain market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 55 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 56 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 57 Norway market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 58 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 59 Japan market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 60 China market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 61 India market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 62 Australia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 63 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 64 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 65 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 66 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 67 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 68 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 69 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 70 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 71 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 72 UAE market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 73 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Contrast Media Market Growth & Trends:

The global contrast media market size is expected to reach USD 10.74 billion by 2030, registering a CAGR of 7.98% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of chronic diseases is fueling the demand for diagnostic imaging treatments, which is propelling the market forward. Imaging studies, such as MRI, have become an important aspect of most disease diagnoses, and the widespread use of imaging technologies in healthcare has boosted the demand for contrast media globally.

Chronic diseases like cancer and diabetes are quickly becoming a major public health concern and are among the leading causes of mortality worldwide, necessitating the development of early detection techniques and effective treatment alternatives. As a result, one of the key drivers of imaging tests and contrast agents is the rising prevalence of complicated comorbidities and long-term disorders, thus boosting the market worldwide.

Due to fewer patient visits to hospitals, the COVID-19 pandemic had a detrimental influence on the global contrast media market. The number of imaging cases in several radiology departments dropped dramatically. Many countries worldwide have begun to rebuild their economy, but it will take time for contrast media utilization rates to return to pre-pandemic levels. Furthermore, with the launch of COVID-19 vaccines and the relaxation of restrictions, raw material imports and exports have begun, indicating that the market will develop at a high rate throughout the projection period.

Contrast Media Market Report Highlights:

• On the basis of modality, the X-ray/Computed Tomography segment held the largest market share in 2023, accounting for 69.64%. Wide acceptance and cost-efficiency of the X-ray/CT modality boost the adoption of contrast agents used for this modality
• Based on product type, the iodinated contrast media segment held the largest market share in 2023, accounting for 65.37%. This is due to their excellent radio-opacity and low toxicity than other agents
• Based on application, the neurological disorders segment dominated the market and held the largest revenue share around 28.59% in 2023. Diagnostic evaluation of CNS for neurological disorders boosts the adoption of MRI contrast agents, as they provide better images of neural structures than CT

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Modality
  • 1.1.2. Product
  • 1.1.3. Application
  • 1.1.4. Route of administration
  • 1.1.5. End-use
  • 1.1.6. Regional scope
  • 1.1.7. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for Primary Interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for Primary Interviews in Latin America
    • 1.3.5.5. Data for Primary Interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Modality outlook
  • 2.2.2. Product outlook
  • 2.2.3. Application outlook
  • 2.2.4. Route of administration outlook
  • 2.2.5. End-use outlook
  • 2.2.6. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Contrast Media Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market Driver Analysis
    • 3.4.1.1. Increasing prevalence of long-term diseases and complex comorbidities
    • 3.4.1.2. Technological advancements
    • 3.4.1.3. Label expansions
  • 3.4.2. Market Restraint Analysis
    • 3.4.2.1. Rising concern about MRI gadolinium agents retained in brain
• 3.5. Contrast Media Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic Landscape
  • 3.5.3. Major Deals & Strategic Alliances Analysis
  • 3.5.4. Market Entry Strategies

Chapter 4. Contrast Media Market: Modality Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. Ultrasound
  • 4.1.2. Magnetic Resonance Imaging
  • 4.1.3. X-ray/Computed Tomography
• 4.2. Modality Market Share, 2023 & 2030
• 4.3. Segment Dashboard
• 4.4. Contrast Media Market by Modality Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5.1. Ultrasound
    • 4.5.1.1. Ultrasound market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. Magnetic Resonance Imaging
    • 4.5.2.1. Magnetic resonance imaging market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.3. X-ray/Computed Tomography
    • 4.5.3.1. X-ray/computed tomography market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Contrast Media Market: Product Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. Microbubble
  • 5.1.2. Gadolinium-Based
  • 5.1.3. Iodinated
  • 5.1.4. Barium-Based
• 5.2. Product Market Share, 2023 & 2030
• 5.3. Segment Dashboard
• 5.4. Contrast Media Market by Product Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5.1. Microbubble
    • 5.5.1.1. Microbubble market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. Gadolinium-Based
    • 5.5.2.1. Gadolinium-based Market Estimates and Forecast 2018 to 2030 (USD Million)
  • 5.5.3. Iodinated
    • 5.5.3.1. Iodinated market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.4. Barium-Based
    • 5.5.4.1. Barium-based Market Estimates and Forecast 2018 to 2030 (USD Million)

Chapter 6. Contrast Media Market: Application Estimates & Trend Analysis

• 6.1. Definitions and Scope
  • 6.1.1. Cardiovascular Disorders
  • 6.1.2. Neurological Disorders
  • 6.1.3. Gastrointestinal Disorders
  • 6.1.4. Cancer
  • 6.1.5. Nephrological Disorders
  • 6.1.6. Musculoskeletal Disorders
  • 6.1.7. Others
• 6.2. Application Market Share, 2023 & 2030
• 6.3. Segment Dashboard
• 6.4. Contrast Media Market by Application Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5.1. Cardiovascular Disorders
    • 6.5.1.1. Cardiovascular disorders market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.2. Neurological Disorders
    • 6.5.2.1. Neurological disorders market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.3. Gastrointestinal Disorders
    • 6.5.3.1. Gastrointestinal disorders market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.4. Cancer
    • 6.5.4.1. Cancer market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.5. Nephrological Disorders
    • 6.5.5.1. Nephrological Disorders Market Estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.6. Musculoskeletal Disorders
    • 6.5.6.1. Musculoskeletal disorders market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.7. Others
    • 6.5.7.1. Others market Estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Contrast Media Market: Route Of Administration Estimates & Trend Analysis

• 7.1. Definitions and Scope
  • 7.1.1. Intravenous
  • 7.1.2. Oral Route
  • 7.1.3. Rectal Route
• 7.2. Route of Administration Market Share, 2023 & 2030
• 7.3. Segment Dashboard
• 7.4. Contrast Media Market by Route of Administration Outlook
• 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5.1. Intravenous
    • 7.5.1.1. Intravenous market Estimates and forecast 2018 to 2030 (USD Million)
  • 7.5.2. Oral Route
    • 7.5.2.1. Oral route market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5.3. Rectal Route
    • 7.5.3.1. Rectal route market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Contrast Media Market: End-use Estimates & Trend Analysis

• 8.1. Definitions and Scope
  • 8.1.1. Hospitals
  • 8.1.2. Diagnostic Imaging Centers
  • 8.1.3. Others
• 8.2. End-use Market Share, 2023 & 2030
• 8.3. Segment Dashboard
• 8.4. Contrast Media Market by End-use Outlook
• 8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 8.5.1. Hospitals
    • 8.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
  • 8.5.2. Diagnostic Imaging Centers
    • 8.5.2.1. Diagnostic imaging centers market estimates and forecast 2018 to 2030 (USD Million)
  • 8.5.3. Others
    • 8.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 9. Contrast Media Market: Regional Estimates & Trend Analysis

• 9.1. Regional market share analysis, 2023 & 2030
• 9.2. Regional Market Dashboard
• 9.3. Global Regional Market Snapshot
• 9.4. Regional Market Share and Leading Players, 2023
  • 9.4.1. North America
  • 9.4.2. Europe
  • 9.4.3. Asia Pacific
  • 9.4.4. Latin America
  • 9.4.5. Middle East and Africa
• 9.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
• 9.6. North America
  • 9.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 9.6.2. U.S.
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Competitive scenario
    • 9.6.2.3. Regulatory framework
    • 9.6.2.4. Reimbursement scenario
    • 9.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
  • 9.6.3. Canada
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Competitive scenario
    • 9.6.3.3. Regulatory framework
    • 9.6.3.4. Reimbursement scenario
    • 9.6.3.5. Canada market estimates and forecasts, 2018 - 2030
• 9.7. Europe
  • 9.7.1. UK
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Competitive scenario
    • 9.7.1.3. Regulatory framework
    • 9.7.1.4. Reimbursement scenario
    • 9.7.1.5. UK market estimates and forecasts, 2018 - 2030
  • 9.7.2. Germany
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Competitive scenario
    • 9.7.2.3. Regulatory framework
    • 9.7.2.4. Reimbursement scenario
    • 9.7.2.5. Germany market estimates and forecasts, 2018 - 2030
  • 9.7.3. France
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Competitive scenario
    • 9.7.3.3. Regulatory framework
    • 9.7.3.4. Reimbursement scenario
    • 9.7.3.5. France market estimates and forecasts, 2018 - 2030
  • 9.7.4. Italy
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Competitive scenario
    • 9.7.4.3. Regulatory framework
    • 9.7.4.4. Reimbursement scenario
    • 9.7.4.5. Italy market estimates and forecasts, 2018 - 2030
  • 9.7.5. Spain
    • 9.7.5.1. Key country dynamics
    • 9.7.5.2. Competitive scenario
    • 9.7.5.3. Regulatory framework
    • 9.7.5.4. Reimbursement scenario
    • 9.7.5.5. Spain market estimates and forecasts, 2018 - 2030
  • 9.7.6. Denmark
    • 9.7.6.1. Key country dynamics
    • 9.7.6.2. Competitive scenario
    • 9.7.6.3. Regulatory framework
    • 9.7.6.4. Reimbursement scenario
    • 9.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
  • 9.7.7. Sweden
    • 9.7.7.1. Key country dynamics
    • 9.7.7.2. Competitive scenario
    • 9.7.7.3. Regulatory framework
    • 9.7.7.4. Reimbursement scenario
    • 9.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
  • 9.7.8. Norway
    • 9.7.8.1. Key country dynamics
    • 9.7.8.2. Competitive scenario
    • 9.7.8.3. Regulatory framework
    • 9.7.8.4. Reimbursement scenario
    • 9.7.8.5. Norway market estimates and forecasts, 2018 - 2030
• 9.8. Asia Pacific
  • 9.8.1. Japan
    • 9.8.1.1. Key country dynamics
    • 9.8.1.2. Competitive scenario
    • 9.8.1.3. Regulatory framework
    • 9.8.1.4. Reimbursement scenario
    • 9.8.1.5. Japan market estimates and forecasts, 2018 - 2030
  • 9.8.2. India
    • 9.8.2.1. Key country dynamics
    • 9.8.2.2. Competitive scenario
    • 9.8.2.3. Regulatory framework
    • 9.8.2.4. Reimbursement scenario
    • 9.8.2.5. India market estimates and forecasts, 2018 - 2030
  • 9.8.3. China
    • 9.8.3.1. Key country dynamics
    • 9.8.3.2. Competitive scenario
    • 9.8.3.3. Regulatory framework
    • 9.8.3.4. Reimbursement scenario
    • 9.8.3.5. China market estimates and forecasts, 2018 - 2030
  • 9.8.4. South Korea
    • 9.8.4.1. Key country dynamics
    • 9.8.4.2. Competitive scenario
    • 9.8.4.3. Regulatory framework
    • 9.8.4.4. Reimbursement scenario
    • 9.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
  • 9.8.5. Australia
    • 9.8.5.1. Key country dynamics
    • 9.8.5.2. Competitive scenario
    • 9.8.5.3. Regulatory framework
    • 9.8.5.4. Reimbursement scenario
    • 9.8.5.5. Australia market estimates and forecasts, 2018 - 2030
  • 9.8.6. Thailand
    • 9.8.6.1. Key country dynamics
    • 9.8.6.2. Competitive scenario
    • 9.8.6.3. Regulatory framework
    • 9.8.6.4. Reimbursement scenario
    • 9.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
• 9.9. Latin America
  • 9.9.1. Brazil
    • 9.9.1.1. Key country dynamics
    • 9.9.1.2. Competitive scenario
    • 9.9.1.3. Regulatory framework
    • 9.9.1.4. Reimbursement scenario
    • 9.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
  • 9.9.2. Mexico
    • 9.9.2.1. Key country dynamics
    • 9.9.2.2. Competitive scenario
    • 9.9.2.3. Regulatory framework
    • 9.9.2.4. Reimbursement scenario
    • 9.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
  • 9.9.3. Argentina
    • 9.9.3.1. Key country dynamics
    • 9.9.3.2. Competitive scenario
    • 9.9.3.3. Regulatory framework
    • 9.9.3.4. Reimbursement scenario
    • 9.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
• 9.10. MEA
  • 9.10.1. South Africa
    • 9.10.1.1. Key country dynamics
    • 9.10.1.2. Competitive scenario
    • 9.10.1.3. Regulatory framework
    • 9.10.1.4. Reimbursement scenario
    • 9.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
  • 9.10.2. Saudi Arabia
    • 9.10.2.1. Key country dynamics
    • 9.10.2.2. Competitive scenario
    • 9.10.2.3. Regulatory framework
    • 9.10.2.4. Reimbursement scenario
    • 9.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
  • 9.10.3. UAE
    • 9.10.3.1. Key country dynamics
    • 9.10.3.2. Competitive scenario
    • 9.10.3.3. Regulatory framework
    • 9.10.3.4. Reimbursement scenario
    • 9.10.3.5. UAE market estimates and forecasts, 2018 - 2030
  • 9.10.4. Kuwait
    • 9.10.4.1. Key country dynamics
    • 9.10.4.2. Competitive scenario
    • 9.10.4.3. Regulatory framework
    • 9.10.4.4. Reimbursement scenario
    • 9.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company/Competition Categorization
  • 10.2.1. Innovators
• 10.3. Vendor Landscape
  • 10.3.1. List of key distributors and channel partners
  • 10.3.2. Key customers
  • 10.3.3. Key company market share analysis, 2023
  • 10.3.4. Bayer AG
    • 10.3.4.1. Company overview
    • 10.3.4.2. Financial performance
    • 10.3.4.3. Product benchmarking
    • 10.3.4.4. Strategic initiatives
  • 10.3.5. General Electric Company
    • 10.3.5.1. Company overview
    • 10.3.5.2. Financial performance
    • 10.3.5.3. Product benchmarking
    • 10.3.5.4. Strategic initiatives
  • 10.3.6. Guerbet
    • 10.3.6.1. Company overview
    • 10.3.6.2. Financial performance
    • 10.3.6.3. Product benchmarking
    • 10.3.6.4. Strategic initiatives
  • 10.3.7. Bracco Diagnostic, Inc.
    • 10.3.7.1. Company overview
    • 10.3.7.2. Financial performance
    • 10.3.7.3. Product benchmarking
    • 10.3.7.4. Strategic initiatives
  • 10.3.8. Nano Therapeutics Pvt. Ltd.
    • 10.3.8.1. Company overview
    • 10.3.8.2. Financial performance
    • 10.3.8.3. Product benchmarking
    • 10.3.8.4. Strategic initiatives
  • 10.3.9. Lantheus Medical Imaging, Inc.
    • 10.3.9.1. Company overview
    • 10.3.9.2. Financial performance
    • 10.3.9.3. Product benchmarking
    • 10.3.9.4. Strategic initiatives
  • 10.3.10. iMAX
    • 10.3.10.1. Company overview
    • 10.3.10.2. Financial performance
    • 10.3.10.3. Product benchmarking
    • 10.3.10.4. Strategic initiatives
  • 10.3.11. Trivitron Healthcare
    • 10.3.11.1. Company overview
    • 10.3.11.2. Financial performance
    • 10.3.11.3. Product benchmarking
    • 10.3.11.4. Strategic initiatives